Development of a novel quality by design–enabled stability‐indicating HPLC method and its validation for the quantification of nirmatrelvir in bulk and pharmaceutical dosage forms

Documenti analoghi

• Stability‐indicating RP‐HPLC method development and validation for the quantification of amlodipine besylate and valsartan tablets in solid oral dosage form
  di: Teja Kamireddy, et al.
  Pubblicazione: (2024)
• Development, evaluation of critical method variables and stability assessment using a Box–Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone
  di: Santhosh Kumar Ettaboina, et al.
  Pubblicazione: (2024)
• Method development and validation of an analytical quality by design ultrafast liquid chromatographic method for the determination of bedaquiline from pharmaceutical bulk and nanoemulsions
  di: Taiwo Oreoluwa Ajayi, et al.
  Pubblicazione: (2024)
• A validated stability‐indicating reversed‐phase‐UPLC method for simultaneous estimation of promethazine hydrochloride, methylparaben, propylparaben and sodium benzoate assay of cough suppressant and antihistamine liquid oral dosage forms
  di: Sreenivas Pippalla, et al.
  Pubblicazione: (2024)
• Development of a green high‐performance liquid chromatography method for tofacitinib quantification in pharmaceutical formulations and degradation studies
  di: Gizem Tiris, et al.
  Pubblicazione: (2024)